Rediscover Microbiology
Rediscover
Microorganisms
Empowering Precision Health via the Gut Microbiota
Expanding our horizons, discovering new insights,
and forging a healthier future through the power of microorganisms.
Expanding our horizons, discovering new insights, and forging a healthier future through the power of microorganisms.
Rediscover Microbiology
Founded in August 2011 as a spin-off from National Taiwan University, Leeuwenhoek Biotech Inc. specializes in microbial multi-omics technology services and is committed to developing
innovative products and solutions that promote metabolic health through gut microbiota modulation..
Rooted in science, we explore groundbreaking applications of the gut microbiome in human health—empowering microbes to become a key force in shaping the future of wellness.
Leeuwenhoek was founded in August 2011 as a start-up company derived from the technology transfer of National Taiwan University. We focus on providing microbial polysomics technology services and are committed to developing innovative services and products that promote metabolic health through intestinal flora regulation.
Rooted in science, we explore groundbreaking applications of the gut microbiome in human health—empowering microbes to become a key force in shaping the future of wellness.
Three core technologies
We house the world’s largest Akkermansia strain biobank for next-generation probiotics,
the third-largest gut microbial metabolomics database globally, and a proprietary synbiotic technology platform
—positioning us at the forefront of gut health research and innovation.
Leeuwenhoek has the world's largest resource library of next-generation probiotic Akkermansia strains, the world's third largest intestinal bacterial metabolite database, and an independently developed next-generation synbiotic technology platform, which establishes our leading position in intestinal health research and application.
Rediscover Microbiology
Leeuwenhoek connects the final piece of the puzzle
Unlocking breakthroughs in the future of biotechnology
Cumulative Samples Analyzed in Taiwan from Dec 2024 to Present
Academic and Research Institutions
Medical Institutions
Industry Clients
Based on scientific evidence and supported by experimental results
Your best partner in research
Latest News & Events
Insights & Highlights
From "Slim Pen" to the Principle and Prospect of Intestinal Probiotic GLP-1 Products
(This article is reproduced from Science Monthly: ) Author: Xu Chengzhi/Associate Professor of Chemistry Department of National Taiwan University, Leeuwenhoek Biotechnology…
Will eating beef and red meat cause heart attack or stroke? Do a test and you will know immediately whether you can eat beef
Eating red meat such as beef can easily lead to myocardial infarction and stroke, but beef is also the best blood-replenishing meat with high iron content. "Is beef suitable for me?" A new startup company derived from the National Taiwan University Hospital's "Can I eat beef?" was created by Wu Mingxian, the director of the National Taiwan University Hospital...
The relationship between antibiotics, intestinal bacteria and obesity in animals
How do antibiotics make the host obese? Antibiotics are the substances that have the most severe impact on intestinal bacteria. According to the study of Reijnders et al., obese subjects were given 1500 mg vancomyc orally for seven consecutive days.